Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy

References

• Recht A. Selecting patients for breast-conserving therapy. Seminars in Breast Disease 2001; 4: 198–206
   Google Scholar
• Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conserving therapy. J Clin Oncol 1994; 12: 653–60
   PubMed Web of Science ®Google Scholar
• Schnitt SJ, Connolly JL. Pathological risk factors for local recurrence in patients with invasive breast cancer treated with conservative surgery and radiation therapy. Seminars in Breast Disease 1999; 2: 230–9
   Google Scholar
• Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 1989; 17: 719–25
   PubMed Web of Science ®Google Scholar
• Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76: 259–67
   PubMed Web of Science ®Google Scholar
• Kini VR, Vicini FA, Frazier R, et al. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 1999; 43: 341–6
   PubMedGoogle Scholar
• Renton SC, Gazet JC, Ford HT, et al. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 1996; 22: 17–22
   PubMedGoogle Scholar
• Voogd AC, Peterse JL, Crommelin MA, et al. Histologic determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Eur J Cancer 1999; 35: 1828–37
   PubMedGoogle Scholar
• Stata/SE 8.2 for Windows. Stata Press; College Station; Stata Corporation: 2004.
   Google Scholar
• Liljegren G, Holmberg L, Bergh J, et al. 10-year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol 1999; 17: 2326–33
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialist’ Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomized trials. Lancet 2000;355:1757–70.
   PubMedGoogle Scholar
• Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Eng J Med 2002; 347: 1233–41
   PubMed Web of Science ®Google Scholar
• Taghian A, Mohiuddin M, Jagsi R, et al. Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey. Ann Surg 2005; 24: 629–39
   Google Scholar
• Cowen D, Houvenaeghel G, Bardou V-J, et al. Local and distant failures after limited surgery with positive margins and radiotherapy for node-negative breast cancer. Int J Radiat Oncol Biol Phys 2000; 47: 305–12
   PubMedGoogle Scholar
• Komoike Y, Akiyama F, Iino Y, et al. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer. Cancer 2006; 106: 35–41
   PubMed Web of Science ®Google Scholar
• Fredriksson I, Liljegren G, Palm-Sjovall M, et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003; 90: 1093–102
   PubMedGoogle Scholar
• Horst KC, Smitt MC, Goffinet DR, et al. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 2005; 5: 425–38
   PubMedGoogle Scholar
• Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 1999; 45: 885–91
   PubMedGoogle Scholar
• Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996; 78: 1921–8
   PubMed Web of Science ®Google Scholar
• Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999; 44: 1005–15
   PubMed Web of Science ®Google Scholar
• Touboul E, Buffat L, Belkacémi Y, et al. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1998; 43: 25–38
   Google Scholar
• Veronesi U, Marubini E, Marubini L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2000; 12: 97–103
   Google Scholar
• Voogd AC, Neilsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomised trials. J Clin Oncol 2001; 19: 1688–97
   PubMed Web of Science ®Google Scholar
• Jobsen JJ, van der Palen J, Meerwaldt JH. The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy. Eur J Cancer 2001; 37: 1820–7
   PubMedGoogle Scholar
• Borg M F. Breast-conserving therapy in young women with invasive carcinoma of the breast. Aus Radial 2004; 48: 376–82
   PubMedGoogle Scholar
• Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma. Cancer 2004; 101: 1264–74
   PubMed Web of Science ®Google Scholar
• Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. The value of a positive margin for invasive carcinoma in breast conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 2003; 57: 724–31
   PubMed Web of Science ®Google Scholar
• Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in situ; analysis of EORTC trial 10853. J Clin Oncol 2001; 19: 2263–71
   PubMed Web of Science ®Google Scholar
• Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441–52
   PubMed Web of Science ®Google Scholar
• Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer 2000; 85: 616–28
   Google Scholar
• Holland R, Connely JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8: 113–8
   PubMed Web of Science ®Google Scholar
• Holland R, Hendriks JHCL, Verbeek ALM, et al. Extent, distribution, and mammograhic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519–22
   PubMed Web of Science ®Google Scholar